Assignment of Assignor's Interest

Recorded: 2022-01-27 Pages: 9

View PDF Order Certified Copy

Assignors

EZEKIAL GOLAN

Executed: 2021-05-06

DIET ALCOHOL CORPORATION OF THE AMERICAS

Executed: 2021-05-07

Assignee

CYNTAR VENTURES, INC.

905-1030 WEST GEORGIA STREET, VANCOUVER, BC V6E 2Y3, CANADA

Covered Properties (7)

Anti-Vasa Antibodies, and Methods of Production and Use Thereof

Application: 62/089,054 →

Binge Behavior Regulators

Patent: 10,137,096 →

Application: 15/534,137 →

Publication: US 2018/0085326

Binge Behavior Regulators

Patent: 10,406,123 →

Application: 16/167,576 →

Publication: US 2019/0054042

Binge Behavior Regulators

Patent: 11,077,072 →

Application: 16/563,974 →

Publication: US 2020/0000747

Binge Behavior Regulators

Patent: 12,064,402 →

Application: 17/371,511 →

Publication: US 2021/0330607

Binge Behavior Regulators

Patent: 12,350,242 →

Application: 17/371,564 →

Publication: US 2021/0330608

Binge Behavior Regulators

Patent: 12,357,590 →

Application: 17/371,626 →

Publication: US 2021/0330609

Related Assignments (3)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Jan 6, 2015

From: WEAVER, DAVID T.; ZHANG, BO

To: OVASCIENCE, INC.

Reel/Frame 034642/0815 →

Change of Name Jan 27, 2022

From: CYNTAR VENTURES, INC.

To: CLEARMIND MEDICINE INC.

Reel/Frame 058797/0479 →

Change of Name Oct 20, 2025

From: CLEARMIND MEDICINE INC.

To: CLEARMIND LABS CORP.

Reel/Frame 072605/0741 →